Cike Peng

406 total citations
13 papers, 293 citations indexed

About

Cike Peng is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cike Peng has authored 13 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cike Peng's work include Colorectal Cancer Treatments and Studies (6 papers), Economic and Financial Impacts of Cancer (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Cike Peng is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Economic and Financial Impacts of Cancer (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Cike Peng collaborates with scholars based in China, Germany and United States. Cike Peng's co-authors include Andreas Schneeweiß, Barbara Burwinkel, Markus Wallwiener, Christof Sohn, Dharanija Madhavan, Anja Rudolph, Andreas Trumpp, Sarah Schott, Juliane Nees and Klaus Pantel and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Carcinogenesis.

In The Last Decade

Cike Peng

13 papers receiving 292 citations

Peers

Cike Peng

ONCOL

PRM

Zhigang Cao China

Fergus Keane United States

Changhao Huang China

Primitiva Menéndez Spain

Sareena Singh United States

Aislinn E. Treloar Canada

Chunjuan Zhao China

Nüket Eliyatkın Türkiye

Justyna Chlebowska Poland

Dae Hwa Choi South Korea

Zhigang Cao China

Cike Peng

229 ×1.2

151 ×1.1

70 ×1.0

ONCOL

39 ×1.2

PRM

13 ×0.4

Citations per year, relative to Cike Peng Cike Peng (= 1×) peers Zhigang Cao

Countries citing papers authored by Cike Peng

Since Specialization

Citations

This map shows the geographic impact of Cike Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cike Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cike Peng more than expected).

Fields of papers citing papers by Cike Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cike Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cike Peng. The network helps show where Cike Peng may publish in the future.

Co-authorship network of co-authors of Cike Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Cike Peng. A scholar is included among the top collaborators of Cike Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cike Peng. Cike Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Qin, Shukui, Yuxian Bai, Yanhong Deng, et al.. (2021). Quality-Adjusted Survival in Patients with Metastatic Colorectal Cancer Treated with Fruquintinib in the FRESCO Trial. Future Oncology. 17(15). 1923–1931. 3 indexed citations

Guan, Xin‐Yuan, Hongchao Li, Xiaomo Xiong, et al.. (2021). Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China. Journal of Medical Economics. 24(1). 339–344. 14 indexed citations

Xu, Rui‐Hua, Wei Wang, Bo Zhu, et al.. (2020). Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China. BMC Cancer. 20(1). 131–131. 24 indexed citations

Shen, Lin, Qi Li, Wei Wang, et al.. (2020). Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China. Journal of Medical Economics. 23(5). 456–463. 23 indexed citations

Shen, Lin, Xiaohua Ying, Wei Wang, et al.. (2018). Treatment Patterns and Economic Burden of Chinese Metastatic Colorectal Cancer Patients: a Retrospective Study of Electronic Medical Records from Urban China. Value in Health. 21. S23–S23. 1 indexed citations

Bai, Yuxian, Shukui Qin, Jin Li, et al.. (2018). Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in the randomized phase III FRESCO trial.. Journal of Clinical Oncology. 36(15_suppl). 3544–3544. 1 indexed citations

Wang, Siqi, Qiuqiong Tang, Jun Fu, et al.. (2016). The effect of ethephon on immune system in male offspring of mice. Environmental Toxicology and Pharmacology. 49. 119–123. 14 indexed citations

Peng, Cike, Hongda Chen, Markus Wallwiener, et al.. (2016). Plasma S100P level as a novel prognostic marker of metastatic breast cancer. Breast Cancer Research and Treatment. 157(2). 329–338. 11 indexed citations

Madhavan, Dharanija, Cike Peng, Markus Wallwiener, et al.. (2016). Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis. Carcinogenesis. 37(5). 461–470. 113 indexed citations

10.

Kriegsmann, Mark, Cike Peng, Ákos Szabó, et al.. (2015). S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer. Experimental and Molecular Pathology. 99(1). 180–187. 18 indexed citations

11.

Peng, Cike, Markus Wallwiener, Anja Rudolph, et al.. (2015). Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer. International Journal of Cancer. 138(10). 2499–2509. 34 indexed citations

12.

Fu, Jun, Cike Peng, Wanyi Wang, et al.. (2011). Let-7g is involved in doxorubicin induced myocardial injury. Environmental Toxicology and Pharmacology. 33(2). 312–317. 35 indexed citations

13.

Su, Kaiyi, et al.. (2007). P.2.b.005 Polymorphisms in cytosolic phospholipase A2 and cyclooxygenase 2 genes and risk of interferon-induced depression. European Neuropsychopharmacology. 17. S334–S335. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact